Related Experiment Video
Updated: Jan 8, 2026

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
Alzheimer's Imaging Consortium
Stuart William Mitchell1,2, Tevy Chan1,2,3, Lydia Trudel1,2,3,4,5,6,7
1Translational Neuroimaging Laboratory, The McGill University Research Centre for Studies in Aging, Montréal, QC, Canada.
Spatial extent of tauopathy (SEOT) better predicts cognitive decline in Alzheimer's disease than tau load (SUVR). SEOT may be a more sensitive marker for neurodegenerative disease progression.
Area of Science:
- Neuroimaging
- Alzheimer's Disease Research
- Cognitive Neuroscience
Background:
- Brain and cognitive resilience (BR, CR) are key to maintaining function despite Alzheimer's disease (AD) tau pathology.
- Tau pathology can be measured by spatial extent (SEOT) or load (SUVR).
- Understanding factors influencing BR and CR is crucial for AD management.
Purpose of the Study:
- Compare SEOT and SUVR in their association with BR and CR.
- Replicate previous findings using MK-6240 PET imaging.
- Evaluate demographic, genetic, and imaging factors linked to BR and CR.
Main Methods:
- 126 amyloid-β-positive participants from the TRIAD cohort underwent tau-PET ([18F]MK6240) and cognitive assessments (MMSE).
- SEOT was quantified as the proportion of voxels with abnormal tau deposition relative to young controls.
- Participants included individuals with mild cognitive impairment (MCI) or AD.
Main Results:
- Higher Whole Cortex MK SUVR correlated with lower MMSE scores, indicating tau pathology is linked to cognitive decline.
- MCI patients showed higher MMSE scores despite some tau accumulation compared to AD patients.
- Whole Cortex SEOT demonstrated a stronger negative correlation with MMSE than SUVR, suggesting SEOT is more sensitive to cognitive decline.
Conclusions:
- Whole Cortex SEOT is a more sensitive marker of cognitive decline in AD and MCI than Whole Cortex MK-6240 SUVR.
- SEOT shows a stronger association with cognitive impairment progression.
- Further research is warranted to validate SEOT as a biomarker for neurodegenerative conditions.
More Related Videos
09:31Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
Published on: March 7, 2019
12:50Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
Published on: April 14, 2014
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Imaging Studies III: Computed Tomography
Imaging Studies IV: Magnetic Resonance Imaging
Brain Imaging
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...